Risperidone treatment of an adolescent with severe posttraumatic stress disorder

Annals of Pharmacotherapy

Volumn 43, Issue 7-8, 2009, Pages 1374-

  Keeshin, Brooks R ^a   Strawn, Jeffrey R ^b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; RISPERIDONE; VALPROATE SEMISODIUM;

ADOLESCENT; ANAMNESIS; BEDTIME DOSAGE; CASE REPORT; CHILD NEGLECT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; LETTER; MALE; MORNING DOSAGE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEXUAL ABUSE; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD ABUSE; CHILD ABUSE, SEXUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FOLLOW-UP STUDIES; HUMANS; MALE; RISPERIDONE; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 67651124968     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M219     Document Type: Letter

References (5)

1. Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry 2008;69:520-525
2. Meighen KG, Hines LA, Lagges AM. Risperidone treatment of preschool children with thermal burns and acute stress disorder. J Child Adolesc Psychopharmacol 2007;17:223-232
3. Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety 2008;25:260-271
4. Dierks MR, Jordan JK, Sheehan AH. Prazosin treatment of nightmares related to posttraumatic stress disorder. Ann Pharmacother 2007;41: 1013-1017 Epub 15 May 2009. DOI 10.1345/aph.1H588
5. Schotte A, Janssen PF, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 1996;124:57-73. (Pubitemid 26112775)